Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4474 Phase 1 Safety, PK, and Pharmacology Study
NCT02454387Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- May 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of ONO-4474 in osteoarthritis (OA) (10 arms), sponsored by Ono Pharmaceutical. Primary endpoint: Number of adverse events. Started May 2015; status: completed.
02
Drugs
ONO-4474
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02454387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02454387.